Synta Pharmaceuticals Corp. (NASDAQ:SNTA)
CAPS Rating:
A biopharmaceutical company focused on discovering, developing and commercializing small molecule drugs that address severe medical conditions with potential markets, including cancer and chronic inflammatory diseases.
RSS Headlines
Fool UK
Recs
poor development record by management will liiely lead to a very weak pipeline